Origin Asset Management LLP United Therapeutics Corp Transaction History

Origin Asset Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 24, 2022	SELL	$166.16 - $213.96 $171,144 - $220,378	-1,030 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$184.32 - $216.08 $283,668 - $332,547	-1,539 Reduced 59.91%	1,030 $222,000
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $2.91 Million - $3.48 Million	-16,191 Reduced 86.31%	2,569 $474,000
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $193,483 - $240,540	1,135 Added 6.44%	18,760 $3.37 Million
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $92,364 - $104,910	-600 Reduced 3.29%	17,625 $2.95 Million
Q4 2020 Feb 12, 2021	BUY	$101.87 - $151.79 $1.86 Million - $2.77 Million	18,225 New	18,225 $2.77 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Origin Asset Management LLP with notifications on news.